INTRODUCTION
============

Obesity is a major public health problem in the world. The number of obese peoples increases significantly, and developing countries are highly concerned ([@b36-jer-12-2-90]). Regular practice of aerobic physical activities is an important mean to prevent chronic diseases ([@b14-jer-12-2-90]). The increase of exercise capacities and physical fitness result in several health benefits ([@b31-jer-12-2-90]). The Australian National Physical Activity Guidelines for Adults recommend more than 30 min of daily physical activity ([@b23-jer-12-2-90]).

A variety of exercise training are used to reduce obesity. The effects of low intensity aerobic exercises ([@b7-jer-12-2-90]; [@b16-jer-12-2-90]), or anaerobic high intensity exercises ([@b27-jer-12-2-90]), have been assessed in obese individuals. [@b14-jer-12-2-90] reported that the benefits in obese patients in weight loss, fat loss and cardiorespiratory fitness improvement were greater when aerobic and anaerobic exercises were combined, compared to single aerobic or anaerobic. Many studies using discontinuous and/or continuous exercises showed comparable effects in taking care of obese individuals ([@b5-jer-12-2-90]; [@b6-jer-12-2-90]). Nevertheless, [@b5-jer-12-2-90] showed that obese patients preferred similarly the constant velocity walk and the intermittent walk because of the break with the monotony of constant velocity (continuous) exercises frequently proposed during training sessions. Other training programs for obese individuals, are based on intermittent and/or repeated short bouts exercises. In an 18-month longitudinal study, [@b15-jer-12-2-90] compared effects of intermittent with traditional continuous exercise on weight loss, adherence and fitness in obese subjects. They found that subjects of short bouts group did not experience improvement in long-term weight loss, exercise participation, or cardiorespiratory fitness, compared to long bout exercises. In another hand, numerous studies compared the effects of long duration exercises to repeated short duration bouts ([@b11-jer-12-2-90]; [@b19-jer-12-2-90]; [@b22-jer-12-2-90]; [@b24-jer-12-2-90]; [@b26-jer-12-2-90]).

In our knowledge, studies using repeated exercises as well as their longitudinal effects are scarce in the literature. The present study aimed to evaluate the effects of a training program based on the repetition of short-time walk sequences as the 6-min walk test (6MWT) on cardiorespiratory responses, physical performance and metabolic parameters in obese black Cameroonian women.

MATERIALS AND METHODS
=====================

Participants
------------

One hundred seventy-four sedentary obese women (body mass index \[BMI\]\>30 kg/m^2^) accepted voluntarily to participate in the study. All are adherents of a rehabilitation center for no more than one month ago with no physical activity history. They expressed their agreement by signing consent prior to the experiment and the experimental protocol was in accordance with the ethical principles the Declaration of Helsinki, 1975. This study was approved by the National Ethics Committee for the Research in Human Health of Ministry of Public Health of Cameroon. Smokers, peoples living with diabetes, those under phospholipid control medications, and those suffering from any disease which could limit walking capacity were excluded; and finally 139 were included. Because of the potential effect of hormones on the physical capacity, participants were divided into three groups: 48 premenopausal (Pre-M) women, 61 postmenopausal (Post-M) women and 30 control (CONT) women.

Protocol design
---------------

The experiment was conducted in 3 sessions (S1, S2, and S3) with 12 weeks between 2 sessions. During the first (S1) and the third (S3) sessions, each participant completed alone two walking tests separated at least by 48 hr: the 2-km walk test (2kmWT) before and the 6-min walk test (6MWT) after. In the second session (S2), only the 6MWT was completed by the participants. The 2kmWT was used for estimation of the maximal oxygen consumption (VO~2max~) using the Urho Kaleva Kekkonen (UKK) method ([@b30-jer-12-2-90]). The 6MWT was used to evaluate the program and determine the intensity of the training exercise.

Rehabilitation program
----------------------

The duration of the rehabilitation period was 24 weeks and 4 days per week, and concerned only the Pre-M and Post-M women. All participants were refrained to carry any other physical activities programs during the 24 weeks, apart from natural and common daily activities inherent to normal basic sedentary life. The participants were not requested to change their lifestyle or feeding habits over the program since forcing excessive diet to elderly women causes reduction in lean mass, which can cause protein loss, cardiac disorders, and severe risk in health ([@b2-jer-12-2-90]). In another regard, in Cameroonian context, diet is a weekly turn over; and we did not modify the diet to effectively see the outcome of the program even in keeping the common and regular diet.

Each session of rehabilitation (1 hr 30 min) consisted of 20-min warm up (slow to moderate walking, stretching, and respiratory gymnastics) and 60-min main exercise. The main exercise consisted in five repetitions of walking during 6 min (6MWT), with 6-min pause period between repetitions. The walking intensity was determined as a percentage of the distance walked during the previous session. For intervention weeks 1 to 12, the intensity of exercise was 95--105% of the 6MWT distance measured in S1; for intervention weeks 12 to 24, the intensity of exercise was 95--105% of the 6MWT distance measured in S2. All recoveries were active made of slow walking, stretching and exercise relaxation with stereotyped gestures for participants.

Tests
-----

Tests were conducted in a handball court, on an oval track (with 1 lap=100 m). During each test, labeled blocks (1--20) were used to determine the number of laps.

The 2kmWT consisted of walking briskly 2,000 m (20 laps) alone; and the time elapsed was registered. This test aimed to estimate the VO~2max~ (mL.O~2~/min/kg) at S1 and S3, and the evaluation of the training program effects.

The 6MWT was performed according to the American Thoracic Society guidelines ([@b1-jer-12-2-90]) in the same court, and the distance covered after 6-min walking (6MWD) was determined by an experimented technician. The technician approached the participant in the last seconds of walk to drop a block in the point reached the 6th min. The 6MWT was performed at S1, S2, and S3. During each test, participants were instructed to walk as far as possible, covering as much ground as possible and received standardized verbal encouragement.

Metabolic parameters
--------------------

Total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), and triglycerides (TG) were determined using a Cardiochek portable whole blood analyzer (Cardiochek PA, Polymer Technology Systems Inc., Indianapolis, IN, USA) at the beginning (S1) and at the end of the program (S3). This method using whole blood collected in from finger-tips was validated by [@b33-jer-12-2-90]. Low density lipoprotein cholesterol (LDL-C) was calculated using the formula: LDL-C=TC--HDL-C--TG/2.18. These measures were realized 48 hr before the physical evaluation at the beginning of the program, and 48 hr after the last test at the end of the program.

Cardiorespiratory parameters
----------------------------

Heart rate (HR) was continuously monitored from rest until the end of each test using a HR monitor Polar RS800CX (Electro Oy, Kempele, Finland) at S1, S2, and S3.

VO~2max~ was calculated at the end of the 2kmWT (S1 and S3) using the UKK method through the Polar Pro trainer 5 software (Electro Oy, Kempele, Finland). This method uses age, sex, weight, height, time elapsed, and HR at the end of the test for the estimation.

Respiratory volumes (forced expiratory volume 1 sec \[FEV~1~\], forced expiratory volume 6 sec \[FEV~6~\] and FEV~1~/FEV~6~ ratio) were determined at S1, S2, and S3 using an electronic peak flow meter (Piko 6, nSpire Health Inc., 1830 Lefthand Circle, Longmont, CO, USA) and oxygen saturation (SpO~2~) was determined at the same time with an electronic pulse oximeter (ChoiceMMed, OxyWatch C20, Beijing, China). These measures were done by the same investigator to guarantee an accurate assessment.

Anthropometric parameters
-------------------------

Weight, body water percentage (H~2~O), lean muscle mass (MM), fat mass (FM), and bone mass (BM) were measured using a bio-impedance-meter scale TANITA BC 532 (Tokyo, Japan). The waist circumference (WC) and the hip circumference (HC) were measured using a nonextensible tape Butterfly. The BMI was calculated using the Quetelet formula BMI (kg/m^2^)=weight (kg)/height^2^ (m^2^).

Statistical analysis
--------------------

Data were analyzed with Statview 5.0 software (SAS Institute Inc., Cary, NC, USA). Data were expressed as mean±standard deviation. The comparison of mean values obtained in each parameter during the 3 sessions in each group was done using repeated measures analysis of variance. When necessary, a Fischer least significant difference *post hoc* test was performed to locate this difference. *t*-test for paired samples permitted to compare the mean values of parameters measured at the beginning and at the end of the program in each group. Comparison of the three groups after the program was done using unpaired *t*-test. The level of significance was set at *P*\<0.05.

RESULTS
=======

Anthropometric and performance parameters of the participants in this study are presented in [Table 1](#t1-jer-12-2-90){ref-type="table"}. At baseline (S1), Pre-M, and Post-M differ significantly for age (*P*=0.000), height (*P*=0.026), and percentage of water (*P*=0.022), but they did not differ for the other parameters measured. Pre-M was also different from CONT for age and height (*P*\<0.05). Six months (24 weeks) rehabilitation program induced a significant improvement of the walk area in six minutes. There was a significant increase of the 6MWD in Pre-M (698.6±63.5 m vs 744.7±49.6 m, *P*\<0.001) in Post-M (705.1±29.8 m vs 730.3±38.6 m, *P*\<0.01) and in CONT (692.3±23.5 m vs 718.7±12.6 m, *P*\<0.05). At the end of the program (S3), anthropometric characteristics of experimental groups were significantly different from CONT for H~2~O, FM, BM, and 6MWD (*P*\<0.05).

The variations of anthropometric parameters during the program are also presented in [Table 1](#t1-jer-12-2-90){ref-type="table"}. Significant changes were recorded in Pre-M and Post-M for weight, BMI and FM. We registered significant variations for WC, HC, H~2~O, MM, and BM only in Post-M. No significant anthropometric variation was noted in CONT. At the end of the program (S3), there was no difference between Pre-M and Post-M anthropometric and performance characteristics.

[Table 2](#t2-jer-12-2-90){ref-type="table"} shows the metabolic and cardiorespiratory parameters of the participants of the study. No statistically significant difference was observed in metabolic parameters and VO~2peak~ between groups at baseline. Significant differences were recorded in FEV~1~/FEV~6~ ratio (*P*=0.021) and SpO~2~ (*P*=0.012) between Pre-M and Post-M. At S3, differences were recorded between Pre-M and Post-M in FEV~1~/FEV~6~ ratio and SpO~2~ (*P*\<0.05) ([Table 2](#t2-jer-12-2-90){ref-type="table"}). We also recorded a significant difference in FEV~1~/FEV~6~ ratio (*P*\<0.05) between Post-M and CONT women.

After the program, all metabolic and cardiorespiratory parameters changed significantly in Pre-M and Post-M, except VO~2peak~, SpO~2~, and HDL-C. No significant variation was noted in calculated VO~2peak~ and SpO~2~ between S1 and S3. HDL-C significantly changed in Post-M (*P*\<0.05). CONT did not experience significant improvement of metabolic and cardiorespiratory parameters. After the program, Except VO~2peak~ and FEV~6~, all the metabolic and cardiorespiratory parameters were different between experimental groups and CONT.

The comparisons of variations for different parameters are summarized in [Table 3](#t3-jer-12-2-90){ref-type="table"}. All the metabolic parameters of experimental groups (Pre-M and Post-M) varied significantly from CONT but, the variation of the 6MWD was greater in Pre-M group (*P*= 0.002). The program induces significant variations of weight (*P*\<0.001) and BMI (*P*\<0.01) in Pre-M and Post-M groups compared to CONT group.

We studied the HR variations during the 3 sessions in Pre-M and Post-M. [Fig. 1](#f1-jer-12-2-90){ref-type="fig"} shows variations of HR during the 6MWT. There was a progressive increase between resting and warm up periods, and from the beginning of the walk until 1/3 of the distance and/or the time. The HR kinetic during the last 2/3 was almost a plateau. For the 3 sessions of walk in 6 min, the HR kinetics was similar with an important plateau during the 3rd session than the 2nd, and significantly more important than the 1st session.

DISCUSSION
==========

The aim of this study was to evaluate the effects of repetition of walking in 6-min sequences based training program, at intensity near that of the maximal of the 6MWT in obese women. The variables studied were anthropometric parameters, cardiorespiratory response, lung function indices, physical performance, and metabolic parameters with respect to menopausal status. The 24 weeks repeated short time walking program induced significant modifications in anthropometric parameters of Post-M. Furthermore, the program resulted in an improvement of physical fitness, cardiorespiratory function and lipid profile of Pre-M and Post-M; these improvements were more important in Pre-M. These results are consistent with those of [@b17-jer-12-2-90] who found that moderated physical activities could improve the quality of life, and reduce risk factors to develop heart diseases, hypertension, many cancers and type 2 diabetes in patients of all ages.

After 24 weeks of training, we recorded significant beneficial decrease in anthropometric parameters in Post-M ([Table 1](#t1-jer-12-2-90){ref-type="table"}). Our results are in accordance with the findings of [@b14-jer-12-2-90] who reported anthropometric and physiological changes after a long training period. In contrary, [@b10-jer-12-2-90] do not found any improvement in weight and body fat following a program of continuous exercises. [@b32-jer-12-2-90] do not also recorded body weight decrease after 6 weeks short-term moderate intensity aerobic exercise training in premenopausal women.

In the present study, the distance covered in 6 min (6MWD) increased significantly over the program in the three groups. Ameliorations of 6.6% (Pre-M, *P*\<0.001), 3.6% (Post-M, *P*\<0.01), and 3.6% (CONT, *P*\<0.05) were found in the 6MWD from S1 to S3. The 6MWD improvement observed in CONT can be explained by the learning effect of repeated sequences. [@b26-jer-12-2-90] also noted in sedentary women, an increase of 6MWD after a training program comprising 3 sequences of 10 min of walk per day, 5 times per week, during 8 weeks. Thus, the intermittent walking program elicited an increase of physical fitness in obese women. Nevertheless, despite the nonsignificance improvement of VO~2peak~ during the program (+8.8% for Pre-M; +7.6% for Post-M, and +3.0% for CONT), this result was in accordance with that of [@b24-jer-12-2-90] in sedentary subjects of both sexes (6.7--7.2%). But, these changes are less than those obtained in the study of [@b29-jer-12-2-90] who evaluated the effects of high intensity intermittent exercise (HIIE) training on fat loss and fasting insulin levels of young women. The HIIE resulted in a significant increase of 23.8% in post versus pretraining peak absolute oxygen uptake ([@b29-jer-12-2-90]). In their study, [@b25-jer-12-2-90] determined if 3 exercise sequences of 10 min per day (3×10) and, 2 sequences of 15 min per day (2×15) were also effective than a simple sequence of 30 min per day (1×30) in the amelioration of VO~2max~ and weight loss. The results of this study showed that exercises completed in several short duration sequences have the same effect as those completed in one continuous sequence, regarding aerobic fitness and weight loss in overweight girls. This improvement during the training program could be the result of an important increase of the cardiac flow and oxygen artero-veinous difference ([@b31-jer-12-2-90]).

In order to determine whether accumulated short bouts of exercise can achieve the same cardiovascular benefits as a single long bout of exercise in sedentary male Japanese workers and to compare the program relative effects on oxidative stress, [@b9-jer-12-2-90] assigned randomly 23 subjects into 2 different exercise programs: a long-bout group (30 min ×1) 3 days per week, and a short-bouts group (10 min ×3) 3 days per week. Measured parameters were examined at baseline and after both 10 and 20 weeks. WC and VO~2max~ significantly improved in long-bout group after 20 weeks while a significant increase was noted after 10 weeks in short-bouts group.

The results of the present study showed a significant improvement (*P*\<0.05) in FEV~1~ and FEV~6~ during the program in Pre-M and Post-M women, and suggested our program can be used to train and ameliorate respiratory muscle strength. These findings agreed with those of [@b18-jer-12-2-90] who analyzed the effects of a 12-week indoor intermittent training program on lung function in children with asthma. They showed significant improvement in FEV~1~, FEV~6~. Then, an indoor intermittent training program improved lung function and a regular physical exercise routine will greatly improve the quality of life. But, SpO~2~ did not significantly change during the program, may be because of the normal status of this parameter at the beginning of the rehabilitation.

Our program induced many cardiorespiratory adaptations which allow an improvement of VO~2max~ and the blood volume. Furthermore, the training program ameliorated the capacity of the cardiovascular system to carry oxygen to tissue, by increasing the number of muscle mitochondrial enzymes and the total number of muscle capillaries ([@b13-jer-12-2-90]). The oxidative enzyme increase occurs 6--8 weeks of training ([@b18-jer-12-2-90]), and we think our long duration training program to induce a significant improvement of the cardiorespiratory fitness of obese women.

The present study found a significant increase (*P*\<0.05) of HR from S1 to S3 ([Fig. 1](#f1-jer-12-2-90){ref-type="fig"}). This HR increase could be explained by the amelioration of the physical performance (6MWD) observed during the program. This result supposed an amelioration of the cardiac reserve from the beginning to the end of the program and confirmed the enhancement of the cardiorespiratory fitness of participants. Therefore, a training program with short time repeated walk seems to induce similar benefits to that obtained by [@b25-jer-12-2-90] with continuous and intermittent work sequences.

Regarding metabolic parameters, the results of the present study demonstrated an amelioration of the lipid status of obese women in experimental groups ([Tables 2](#t2-jer-12-2-90){ref-type="table"} and [3](#t3-jer-12-2-90){ref-type="table"}). Furthermore, these variations are significant in Pre-M and Post-M compared to CONT. This result suggests that 24-week short time walking program have beneficial effect in obese women. Previous research demonstrated that high-intensity intermittent exercise enhances capacity for fat oxidation and mitochondrial enzyme activity ([@b4-jer-12-2-90]; [@b28-jer-12-2-90]; [@b29-jer-12-2-90]). Physical activity induces an important production of catecholamine which permits fat absorption and these hormones enable the adiposity liberation of free fatty acids by stimulating the adenylyl cyclase enzyme, starting point of TG hydrolysis ([@b21-jer-12-2-90]).

In fact, we noted in Pre-M and Post-M a significant decrease of TC and LDL-C (*P*\<0.01), and TG (*P*\<0.05). But, we observed a significant increase of HDL-C after 24 weeks training program (*P*\<0.05) only in Post-M ([Table 2](#t2-jer-12-2-90){ref-type="table"}). A 24-week training program based on the repetition of short-time walk sequences induces better metabolic status in obese women. Its effects seem marked in Post-M as indicated in HDL-C concentration of Pre-M and Post-M. [@b37-jer-12-2-90] examined the effects of 12-week exercise walking on serum lipids in pre- and postmenopausal women, to elucidate the influence of menopausal status on the training effects. They noted after 12 weeks a significant decrease of body fat percentage in both groups and BMI only in premenopausal group. They also obtained common significant changes of TC, TG, HDL-C, and LDL-C in both groups. These results are in accordance with those of [@b9-jer-12-2-90] who obtained a significant increase in HDL-C after 20 weeks in the short-bouts group. These authors suggested that accumulated short bouts of exercise are an effective option for incorporating exercise into one's lifestyle. A muscle metabolism orientated to lipid utilization than glycogen could justify these variations ([@b3-jer-12-2-90]). The program developed cellular and hormonal adaptations, increased the concentration of the lipoprotein lipase enzyme for lipid oxidation ([@b12-jer-12-2-90]). Aerobic training improves FM utilization by increasing the action of lipid β-oxidation enzyme ([@b34-jer-12-2-90]).

The improvement of the cardiorespiratory response observed during the present study trained an increase of muscle oxygen extraction in organism which implies the utilization of lipid molecules. This type of exercise as the high-intensity intermittent exercise may result in enhanced lipid utilization ([@b29-jer-12-2-90]). Numerous previous studies showed similar results. [@b8-jer-12-2-90] obtained a blood lipid concentration improvement during a longitudinal program of 15--20 miles jogging or briskly walk per week. Ameliorations of cholesterol (13%) and triacylglycerol (37%) were recorded in sedentary obese men, from the beginning to the end of a high intensity circuit training of 30 min/session, for a total of 6-hr exertion ([@b20-jer-12-2-90]). When comparing the physical training effects in blood lipids, [@b10-jer-12-2-90] obtained different results following a 6-min intermittent walking program. In fact, the blood concentration of lipids did not change with training. Furthermore, [@b35-jer-12-2-90] did not experience any variation of HDL-C, LDL-C, and TC after 18-week walking program.

In conclusion, this study showed that 24-week repeated short time walking program improved anthropometric parameters, physical fitness, cardiorespiratory response and lipid profile in obese women. These changes tended to be amplified in Post-M than Pre-M women. Twenty-four-week repeated walking improved pulmonary function, but did not train any significant variation of SpO~2~ in obese women. Repeated short time walking program could be used as an option for the management of obesity. This training modality could be implemented in rehabilitation program as an alternative to high intensity interval training or moderate intensity continuous training.

One limitation of this study is lack of assessment of quantity of calories intake by participants during the program. It would have also been interesting to see variations in blood pressure as a factor associated to obesity.

The authors thank all the women who participated in this study. They are members of the Women National Institute of Youth and Sports Fitness Club.

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

![Kinetics of heart rate during the 6-min walk test in the 3 sessions for the whole population (S1, S2, S3). \*Significant difference of HR between S3 and S1 at *P*\<0.05. HR, heart rate; R~0~, resting HR.](jer-12-2-90f1){#f1-jer-12-2-90}

###### 

Variation of anthropometrics parameters and performance of the participants during the program

  Parameter       CONT (n=30)                                           Pre-M (n=48)                                                                                       Post-M (n=61)                                                                                                                                                                                                                                                                                                                                             
  --------------- ----------------------------------------------------- -------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------- ---------------------------------------------------------- ------------------------------------------------------------- ------------ ------------ -----------------------------------------------------------
  Age (yr)        48.7±9.4[α](#tfn2-jer-12-2-90){ref-type="table-fn"}   39.7±7.9                                                                                           55.0±2.5[πππ](#tfn7-jer-12-2-90){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Height (cm)     164.5±5.8                                             170.3±4.7[α](#tfn2-jer-12-2-90){ref-type="table-fn"},[π](#tfn4-jer-12-2-90){ref-type="table-fn"}   163.1±5.0                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Weight (kg)     91.2±13.3                                             92.7±13.5                                                                                          92.3±13.4[α](#tfn2-jer-12-2-90){ref-type="table-fn"}                                                                                             103.6±22.1                                            103.9±22.0                                                 102.8±21.9[\*](#tfn8-jer-12-2-90){ref-type="table-fn"}        87.5±6.9     87.2±7.0     86.9±7.1[\*\*](#tfn12-jer-12-2-90){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  BMI (kg/m^2^)   33.9±6.3                                              34.7±6.0                                                                                           34.6±5.9                                                                                                                                         35.6±6.7                                              35.5±6.7                                                   35.3±6.7[\*](#tfn8-jer-12-2-90){ref-type="table-fn"}          33.0±2.7     32.8±2.8     32.7±2.8[\*\*](#tfn12-jer-12-2-90){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  WC (cm)         98.4±12.4                                             97.4±10.8                                                                                          98.2±10.3                                                                                                                                        101.1±11.6                                            101.4±11.3                                                 101.2±12.0                                                    94.4±10.2    94.3±10.2    94.2±10.3[\*](#tfn8-jer-12-2-90){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  HC (cm)         120.4±9.2                                             119.8±6.8                                                                                          119.5±8.7                                                                                                                                        123.4±8.9                                             122.8±9.1                                                  123.7±3.3                                                     115.1±6.2    115.1±6.2    115.0±6.2[\*](#tfn8-jer-12-2-90){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  WC/HC (cst)     0.8±0.1                                               0.8±0.1                                                                                            0.8±0.1                                                                                                                                          0.8±0.04                                              0.8±0.04                                                   0.8±0.03                                                      0.8±0.1      0.8±0.1      0.8±0.1
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  H~2~O (%)       39.4±2.1                                              39.6±2.4                                                                                           40.0±2.1[α](#tfn2-jer-12-2-90){ref-type="table-fn"},[β](#tfn3-jer-12-2-90){ref-type="table-fn"}                                                  38.1±1.9[π](#tfn4-jer-12-2-90){ref-type="table-fn"}   38.1±1.9                                                   38.2±2.0                                                      40.9±1.6     41.2±1.7     41.5±1.7[\*\*\*](#tfn13-jer-12-2-90){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  MM (%)          47.1±4.6                                              48.4±4.2                                                                                           48.2±3.8                                                                                                                                         49.9±5.3                                              50.0±4.7                                                   50.2±4.9                                                      46.1±2.7     46.6±2.7     46.9±2.7[\*\*](#tfn12-jer-12-2-90){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  FM (%)          44.8±3.8                                              45.2±3.5                                                                                           44.4±3.7[α](#tfn2-jer-12-2-90){ref-type="table-fn"},[β](#tfn3-jer-12-2-90){ref-type="table-fn"}                                                  47.2±3.4                                              46.7±3.4                                                   46.4±3.5[\*\*](#tfn12-jer-12-2-90){ref-type="table-fn"}       42.9±2.9     42.2±2.7     41.6±2.8[\*\*\*](#tfn13-jer-12-2-90){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  BM (%)          2.5±0.2                                               2.6±0.2                                                                                            2.6±0.2[α](#tfn2-jer-12-2-90){ref-type="table-fn"},[β](#tfn3-jer-12-2-90){ref-type="table-fn"}                                                   2.7±0.3                                               2.7±0.3                                                    2.7±0.3                                                       2.5±0.1      2.5±0.2      2.6±0.2[\*\*](#tfn12-jer-12-2-90){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  6MWD (m)        692.3±23.5                                            701.2±18.1                                                                                         718.7±12.6[\*](#tfn8-jer-12-2-90){ref-type="table-fn"},[α](#tfn2-jer-12-2-90){ref-type="table-fn"},[β](#tfn3-jer-12-2-90){ref-type="table-fn"}   698.6±63.5                                            721.0±53.6[μ,£](#tfn11-jer-12-2-90){ref-type="table-fn"}   744.7±49.6[\*\*\*](#tfn13-jer-12-2-90){ref-type="table-fn"}   705.1±29.8   721.1±35.2   730.3±38.6[\*\*](#tfn12-jer-12-2-90){ref-type="table-fn"}

Values are presented as mean±standard deviation.

Difference between CONT and Pre-M.

Difference between CONT and Post-M.

Difference between Pre-M and Post-M.

*P*\<0.05.

*P*\<0.01.

*P*\<0.001.

Difference between S1 and S3.

Difference between S1 and S2.

Difference between S2 and S3.

*P*\<0.05.

*P*\<0.01.

*P*\<0.001.

CONT, control; Pre-M, premenopausal; Post-M, postmenopausal; BMI, body mass index; WC, waist circumference; HC, hip circumference; MM, muscle mass; FM, fat mass; BM, bone mass; 6MWD, six-min walk distance.

###### 

Variation of metabolic and cardiorespiratory parameters in each group of participants during the program

  Parameter               CONT (n=30)                                             Pre-M (n=48)                                                                                          Post-M (n=61)                                                                                                                
  ----------------------- ------------------------------------------------------- ----------------------------------------------------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------- ----------- -----------------------------------------------------------------------------------------------------
  VO~2peak~ (mL/kg/min)   23.0±5.5                                                23.7±5.2                                                                                              23.8±7.0                                                25.9±7.2                                                 24.9±4.7    26.8±4.9
  TC (g/L)                2.1±0.4                                                 2.3±0.4[α](#tfn16-jer-12-2-90){ref-type="table-fn"}                                                   2.1±0.3                                                 1.8±0.3[\*](#tfn22-jer-12-2-90){ref-type="table-fn"}     2.2±0.3     1.9±0.3[\*](#tfn22-jer-12-2-90){ref-type="table-fn"}
  TG (g/L)                1.1±0.5                                                 1.2±0.3[α](#tfn16-jer-12-2-90){ref-type="table-fn"},[β](#tfn17-jer-12-2-90){ref-type="table-fn"}      1.3±0.3                                                 0.9±0.2[\*\*](#tfn23-jer-12-2-90){ref-type="table-fn"}   1.3±0.3     1.0±0.2[\*\*](#tfn23-jer-12-2-90){ref-type="table-fn"}
  LDL-C (g/L)             1.3±0.1                                                 1.4±0.2[α](#tfn16-jer-12-2-90){ref-type="table-fn"},[β](#tfn17-jer-12-2-90){ref-type="table-fn"}      0.9±0.3                                                 0.7±0.2[\*](#tfn22-jer-12-2-90){ref-type="table-fn"}     1.2±0.3     0.8±0.2[\*](#tfn22-jer-12-2-90){ref-type="table-fn"}
  HDL-C (g/L)             0.6±0.2                                                 0.6±01[α](#tfn16-jer-12-2-90){ref-type="table-fn"}                                                    0.6±0.2                                                 0.7±0.2                                                  0.5±0.2     0.7±0.1[\*](#tfn22-jer-12-2-90){ref-type="table-fn"}
  FEV~1~                  1.93±0.28                                               1.95±0.16[αα](#tfn20-jer-12-2-90){ref-type="table-fn"},[β](#tfn17-jer-12-2-90){ref-type="table-fn"}   1.87±0.27                                               2.32±0.14[\*](#tfn22-jer-12-2-90){ref-type="table-fn"}   1.68±0.29   2.12±0.17[\*](#tfn22-jer-12-2-90){ref-type="table-fn"}
  FEV~6~                  2.24±0.33                                               2.21±0.47                                                                                             2.33±0.45                                               2.91±0.39[\*](#tfn22-jer-12-2-90){ref-type="table-fn"}   2.41±0.50   2.84±0.25[\*](#tfn22-jer-12-2-90){ref-type="table-fn"}
  FEV~1~/FEV~6~           0.86±0.04[β](#tfn17-jer-12-2-90){ref-type="table-fn"}   0.88±0.02[α](#tfn16-jer-12-2-90){ref-type="table-fn"},[β](#tfn17-jer-12-2-90){ref-type="table-fn"}    0.80±0.03[π](#tfn18-jer-12-2-90){ref-type="table-fn"}   0.81±0.04[\*](#tfn22-jer-12-2-90){ref-type="table-fn"}   0.70±0.07   0.74±0.06[\*](#tfn22-jer-12-2-90){ref-type="table-fn"},[π](#tfn18-jer-12-2-90){ref-type="table-fn"}
  SpO~2~                  96.7±1.2                                                96.2±0.92[α](#tfn16-jer-12-2-90){ref-type="table-fn"},[β](#tfn17-jer-12-2-90){ref-type="table-fn"}    98.7±0.57[π](#tfn18-jer-12-2-90){ref-type="table-fn"}   98.7±0.32                                                97.0±0.54   97.83±0.43[π](#tfn18-jer-12-2-90){ref-type="table-fn"}

Values are presented as mean±standard deviation.

Difference between CONT and Pre-M.

Difference between CONT and Post-M.

Difference between Pre-M and Post-M.

*P*\<0.05;

*P*\<0.01.

Difference between S1 and S3.

*P*\<0.05.

*P*\<0.01.

VO~2peak~, peak of oxygen consumption; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; TC, total cholesterol; FEV~1~, forced expiratory volume 1 sec; FEV~6~, forced expiratory volume 6 sec; SpO~2~, oxygen saturation.

###### 

Comparison of anthropometric and metabolic variations from S1 to S3

  Parameter                                                             CONT (n=30)                                                                                              Pre-M (n=48)                                                    Post-M (n=61)
  --------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------- --------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}Weight (kg)               +0.36±0.49[ααα,βββ](#tfn30-jer-12-2-90){ref-type="table-fn"}                                             −0.77±0.35[\*\*](#tfn33-jer-12-2-90){ref-type="table-fn"}       −0.67±0.55[\*\*](#tfn33-jer-12-2-90){ref-type="table-fn"}
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}BMI (kg/m^2^)             +0.13±0.20[αα,ββ](#tfn29-jer-12-2-90){ref-type="table-fn"}                                               −0.26±0.14[\*\*](#tfn33-jer-12-2-90){ref-type="table-fn"}       −0.26±0.22[\*\*](#tfn33-jer-12-2-90){ref-type="table-fn"}
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}WC (cm)                   −0.21±0.70                                                                                               +0.07±0.85                                                      0.20±0.26[\*](#tfn32-jer-12-2-90){ref-type="table-fn"},[π](#tfn27-jer-12-2-90){ref-type="table-fn"}
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}HC (cm)                   +0.77±0.73[α](#tfn25-jer-12-2-90){ref-type="table-fn"},[ββ](#tfn29-jer-12-2-90){ref-type="table-fn"}     +0.22±2.64                                                      −0.09±0.13[\*](#tfn32-jer-12-2-90){ref-type="table-fn"},[π](#tfn27-jer-12-2-90){ref-type="table-fn"}
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}H2O (%)                   −0.06±0.98                                                                                               +0.12±0.59                                                      +0.61±0.24[\*\*\*](#tfn34-jer-12-2-90){ref-type="table-fn"}
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}MM (%)                    +0.23±0.86                                                                                               +0.26±0.60                                                      +0.74±0.60[\*\*\*](#tfn34-jer-12-2-90){ref-type="table-fn"}
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}FM (%)                    +0.31±0.46[αα](#tfn29-jer-12-2-90){ref-type="table-fn"},[βββ](#tfn30-jer-12-2-90){ref-type="table-fn"}   −0.87±0.53[\*\*\*](#tfn34-jer-12-2-90){ref-type="table-fn"}     −1.22±0.63[\*\*\*](#tfn34-jer-12-2-90){ref-type="table-fn"},[π](#tfn27-jer-12-2-90){ref-type="table-fn"}
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}BM (%)                    +0.03±0.09                                                                                               +0.03±0.10                                                      +0.10±0.09[\*\*](#tfn33-jer-12-2-90){ref-type="table-fn"}
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}6MWD                      +11.89±9.35                                                                                              +46.11±36.20[\*\*\*](#tfn34-jer-12-2-90){ref-type="table-fn"}   +26.33±11.69[\*\*](#tfn33-jer-12-2-90){ref-type="table-fn"},[π](#tfn27-jer-12-2-90){ref-type="table-fn"}
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}VO~2\ peak~ (mL/kg/min)   +0.2±0.4[ααα,βββ](#tfn30-jer-12-2-90){ref-type="table-fn"}                                               +2.1±0.7                                                        +1.8±0.7
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}TC (g/L)                  +0.04±0.05[α](#tfn25-jer-12-2-90){ref-type="table-fn"},[β](#tfn26-jer-12-2-90){ref-type="table-fn"}      −0.37±0.42[\*](#tfn32-jer-12-2-90){ref-type="table-fn"}         −0.34±0.25[\*](#tfn32-jer-12-2-90){ref-type="table-fn"}
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}TG (g/L)                  +0.03±0.04[ααα](#tfn30-jer-12-2-90){ref-type="table-fn"},[ββ](#tfn29-jer-12-2-90){ref-type="table-fn"}   −0.39±0.24[\*\*](#tfn33-jer-12-2-90){ref-type="table-fn"}       −0.35±0.2[\*\*](#tfn33-jer-12-2-90){ref-type="table-fn"},[π](#tfn27-jer-12-2-90){ref-type="table-fn"}
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}LDL-chol. (g/L)           +0.04±0.06[α](#tfn25-jer-12-2-90){ref-type="table-fn"},[β](#tfn26-jer-12-2-90){ref-type="table-fn"}      −0.29±0.38[\*](#tfn32-jer-12-2-90){ref-type="table-fn"}         −0.31±0.29[\*](#tfn32-jer-12-2-90){ref-type="table-fn"}
  [Δ](#tfn31-jer-12-2-90){ref-type="table-fn"}HDL-chol. (g/L)           −0.01±0.04[α](#tfn25-jer-12-2-90){ref-type="table-fn"},[β](#tfn26-jer-12-2-90){ref-type="table-fn"}      +0.10±0.05                                                      +0.13±0.12[\*](#tfn32-jer-12-2-90){ref-type="table-fn"},[π](#tfn27-jer-12-2-90){ref-type="table-fn"}

Difference between CONT and Pre-M.

Difference between CONT and Post-M.

Difference between Pre-M and Post-M.

*P*\<0.05.

*P*\<0.01.

*P*\<0.001.

Δ, variation; BMI, body mass index; WC, waist circumference; HC, hip circumference; MM, muscle mass; FM, fat mass; BM, bone mass; VO~2peak~, peak of oxygen consumption; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; TG, triglycerides; TC, total cholesterol; 6MWD, six-min walk distance.

*P*\<0.05.

*P*\<0.01.

*P*\<0.001.
